Related Experiment Video

Updated: May 16, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

[Current therapeutic options in retinopathy of prematurity]

T U Krohne1, S Aisenbrey, F G Holz

  • 1Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. krohne@uni-bonn.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|December 6, 2012
PubMed

Insights

Retinopathy of prematurity, a leading cause of infant blindness, can be prevented with timely treatments like laser therapy or anti-VEGF drugs. Understanding treatment options is key for preserving vision in affected children.

Area of Science:

  • Ophthalmology
  • Neonatal Medicine
  • Retinal Diseases

Context:

  • Retinopathy of prematurity (ROP) is a significant cause of preventable blindness in infants.
  • Early detection and intervention are critical for managing ROP.
  • The avascular peripheral retina in ROP secretes vascular endothelial growth factor (VEGF), driving abnormal blood vessel growth.

Purpose:

  • To review current therapeutic strategies for retinopathy of prematurity.
  • To emphasize the importance of timely and appropriate treatment for optimal visual outcomes.
  • To discuss the role of retinal ablative therapies and anti-VEGF treatments in managing ROP.

Summary:

  • Retinal ablative therapies, including laser coagulation, reduce VEGF secretion from the peripheral retina.
  • Intravitreal injections of VEGF-inhibitory drugs are effective in blocking VEGF activity.
  • Surgical intervention may be necessary for advanced stages of retinopathy of prematurity.

Impact:

  • Effective management of ROP can prevent visual loss and preserve sight in affected children.
  • Knowledge of treatment indications and techniques is crucial for ophthalmologists and neonatologists.
  • Advances in ROP treatment offer hope for improved long-term visual prognoses.

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...